TESTICULAR CANCER SOCIETY
Data sourced from IRS 990 public filings
TESTICULAR CANCER SOCIETY THE ORGANIZATION'S PRIMARY PURPOSE IS TO PROVIDE INCREASED AWARENESS ABOUT TESTICULAR CANCER, PROVIDE EDUCATION AND RESOURCES FOR TESTICULAR CANCER PATIENTS AND SURVIVORS AND TO PROVIDE AID AND SUPPORT OF RESEARCH AND TESTING RELATED TO TESTICULAR CANCER.
TESTICULAR CANCER SOCIETY has received 8 grants from 7 known foundation funders. Revenue decreased from $168,040 in 2024 to $124,442 in 2025. Most recent reported revenue: $124,442.
Annual Revenue
$124,442
Known Funders
7
Grants Received
8
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $124,442 | $208,765 | $292,226 |
| 2024 | $168,040 | $157,969 | $376,549 |
| 2023 | $162,025 | $187,187 | $366,478 |
| 2022 | $392,293 | $180,365 | $394,759 |
| 2021 | $216,084 | $82,123 | $182,841 |
Top Funders
EMERYVILLE, CA
Washington, DC
TAMPA, FL
AMES, IA
Washington, DC
Rolling Meadows, IL
Wilmington, DE
SEATTLE, WA
Key Personnel
From 2025 IRS 990 filing
MICHAEL CRAYCRAFT
PRESIDENT/DIRECTOR
DAVE FINKLANG
DIRECTOR
JASON HOGREFE
DIRECTOR
THAD SCHOEN
DIRECTOR
JEFF STUDENKA
DIRECTOR
ALEN AMINI
DIRECTOR
TONY GATTI
DIRECTOR
GARY KREIGH
TREASURER (FROM 2/4/2025)
Frequently Asked Questions
Other Nonprofits in Ohio
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.